| Trial ID: | L7116 |
| Source ID: | NCT01432405
|
| Associated Drug: |
Exenatide
|
| Title: |
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01432405/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Exenatide|DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: Hepatic Fat, The effect of exenatide and pioglitazone on liver fat content after one year of treatment in patients with type 2 diabetes., one year | Secondary: Plasma Adipocytokines, the effect of the intervention on plasma adiponectin levels., one year
|
| Sponsor/Collaborators: |
Sponsor: Baylor College of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-06
|
| Completion Date: |
2009-06
|
| Results First Posted: |
2016-04-12
|
| Last Update Posted: |
2016-04-12
|
| Locations: |
Baylor College of Medicine, Houston, Texas, 77030, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01432405
|
